Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report) reached a new 52-week low during trading on Thursday . The stock traded as low as $9.22 and last traded at $9.22, with a volume of 20200 shares. The stock had previously closed at $10.51.
Ono Pharmaceutical Trading Down 12.3 %
The company has a market cap of $4.33 billion, a price-to-earnings ratio of 6.88 and a beta of 0.59. The stock’s 50-day moving average is $10.46 and its 200-day moving average is $12.57.
Ono Pharmaceutical (OTCMKTS:OPHLF – Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The company reported $0.24 earnings per share for the quarter. Ono Pharmaceutical had a net margin of 19.64% and a return on equity of 11.80%. The business had revenue of $824.42 million for the quarter.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- Investing In Automotive Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What Are Dividend Contenders? Investing in Dividend Contenders
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Insider Buying Explained: What Investors Need to Know
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
